QQ客服 官方微博 反馈留言

	MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3 beta/E-cadherin pathway
	Zhou, Chunxian; Cui, Fengyun; Li, Jiali; Wang, Diyi; Wei, Yingze; Wu, Ying; Wang, Jiping; Zhu, Hongguang; Wang, Shuyang
刊名	ONCOTARGET
	2017
卷号	8期号:30
关键词	non-metastatic colorectal cancer prognosis biomarker microRNA AKT pathway
ISSN号	1949-2553
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3622154
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhou, Chunxian,Cui, Fengyun,Li, Jiali,et al. MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3 beta/E-cadherin pathway[J]. ONCOTARGET,2017,8(30).
APA	Zhou, Chunxian.,Cui, Fengyun.,Li, Jiali.,Wang, Diyi.,Wei, Yingze.,...&Wang, Shuyang.(2017).MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3 beta/E-cadherin pathway.ONCOTARGET,8(30).
MLA	Zhou, Chunxian,et al."MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3 beta/E-cadherin pathway".ONCOTARGET 8.30(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。